Molecular classification of patients with malignant melanoma for new therapeutic strategies
- PMID: 17538155
- DOI: 10.1200/JCO.2007.11.0965
Molecular classification of patients with malignant melanoma for new therapeutic strategies
Comment on
-
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.J Clin Oncol. 2006 Oct 10;24(29):4738-45. doi: 10.1200/JCO.2006.06.0483. Epub 2006 Sep 11. J Clin Oncol. 2006. PMID: 16966688 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical